North America to Dominate Dementia and Alzheimer’s Disease Treatment Market During Forecast Period
Increased geriatric
population and growing awareness among people about the Alzheimer’s disease to
drive global dementia and alzheimer’s disease treatment market
According
to TechSci Research report, “Global Dementia
and Alzheimer’s Disease Treatment Market By Drug Class, By Distribution
Channel, By Region, Competition, Forecast & Opportunities, 2025”,
Global dementia and alzheimer’s disease treatment market is estimated to
witness significant CAGR during the forecast period. Increasing prevalence of
AD worldwide is one of the
major factors accounting for the growth of global dementia and
alzheimer’s disease treatment market. Moreover, advances in diagnostic
capabilities is expected to bode well for the growth of global dementia and
alzheimer’s disease treatment market through the forecast period. In addition
to this, mounting cases of mild cognitive impairment across the globe is positively
influencing the growth of global dementia and alzheimer’s disease treatment market.
Also, growing awareness and development of newer therapies with maximum
therapeutic effects, is making headway for the growth of global dementia and
alzheimer’s disease treatment market. Furthermore, investment in biomarkers for
drug development is also contributing to increasing market growth. However,
there are certain factors that might hamper the growth of global dementia and
alzheimer’s disease treatment market over the coming years such as high cost of
advanced treatments and severe side-effects associated with certain treatments such
as nausea, insomnia, diarrhea, fatigue and anorexia.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Dementia and
Alzheimer’s Disease Treatment Market "
https://www.techsciresearch.com/report/dementia-and-alzheimers-disease-treatment-market/5058.html
Global
dementia and alzheimer’s disease treatment market can be segmented based on drug
class, distribution channel, company, and region. Considering the distribution
channel, the market is fragmented into hospital pharmacies, retail pharmacies
and online pharmacies. Among these, the hospital pharmacies segment dominated
the global dementia and alzheimer’s disease treatment market in terms of
largest market share until 2019 and is further anticipated to maintain its
dominance during the forecast period as well which can be accredited to availability
of cheap and cost effective medicines at pharmacies in hospitals for the
treatment of AD. Moreover, enhanced safety of replacement therapy by using
recombinant factor concentrates, is further boosting the segmental growth.
Also, the online pharmacies segment is anticipated to rise at a considerable
CAGR during the next 5 years, which is attributed to the presence of
considerable discounts online coupled with easy availability of drugs at home.
Moreover, for long-term treatment required for the treatment of alzheimer’s disease,
buying through online pharmacies is preferred, which is boosting the segmental
growth.
Merz
Pharma GmbH & Co. KGaA, Novartis AG, Allergan plc., Pfizer, Inc., Daiichi
Sankyo Company, Limited, Ono Pharmaceutical Co., Ltd., Johnson & Johnson
Services, Inc., Eisai Co., Ltd., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd.,
AbbVie Inc., Eli Lilly and Company, Biogen, INmuneBIO, AstraZeneca among others
are the leading players operating in global dementia and alzheimer’s disease
treatment market. The leading players are adopting several growth strategies to
enhance the market scenario of dementia and alzheimer’s disease treatment. Other
competitive strategies include mergers & acquisitions; agreements,
partnerships, and collaborations; and expansions to diverse their product
portfolio in order to strengthen their market position.
download
sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5058
customers can also
request for 10% free customization on this report.
“North America is forecast to dominate the global dementia and
alzheimer’s disease treatment market until 2025 on account of high awareness
regarding alzheimer’s disease in the region. Furthermore, growing requirement
for advanced therapies along with disease modifying drugs are also contributing
to the growing trend. Additionally, improving health care infrastructure in the
region is anticipated to bolster the growth of global dementia and alzheimer’s disease
treatment market over the coming years.”, said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“Global Dementia and Alzheimer’s Disease Treatment
Market By Drug Class, By Distribution Channel, By Region, Competition, Forecast
& Opportunities, 2025” has
evaluated the future growth potential of global dementia and alzheimer’s disease
treatment market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global dementia and
alzheimer’s disease treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]